Testing effectiveness (Phase 2)UnknownNCT00003327What this trial is testingPaclitaxel in Treating Patients With Recurrent or Refractory Head and Neck CancerWho this might be right forHead and Neck Cancer Theradex 60
Testing effectiveness (Phase 2)Study completedNCT00330382What this trial is testingBowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral LeukoplakiaWho this might be right forLip and Oral Cavity CancerOral LeukoplakiaOropharyngeal Cancer+1 more National Cancer Institute (NCI) 325
Early research (Phase 1)WithdrawnNCT02812056What this trial is testingAlisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated MalignanciesWho this might be right forMalignant Neoplasms of Digestive OrgansMalignant Neoplasms of Female Genital OrgansMalignant Neoplasms of Lip Oral Cavity and Pharynx+1 more M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07567742What this trial is testingTaurine for the Prevention and Treatment of Radiation-induced Oral Mucositis in Patients With Nasopharyngeal CarcinomaWho this might be right forOral Mucositis (Ulcerative) Due to RadiationNasopharyngeal Carcinoma (NPC) Sun Yat-sen University 130
Large-scale testing (Phase 3)Study completedNCT00964977What this trial is testingEffectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis.Who this might be right forOropharyngeal CancerOral CancerLymph Node Metastasis Johannes Gutenberg University Mainz 209
Testing effectiveness (Phase 2)Looking for participantsNCT05136196What this trial is testingBiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot StudyWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+22 more National Cancer Institute (NCI)
Not applicableLooking for participantsNCT05892354What this trial is testingEffect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After ChemoradiotherapyWho this might be right forLocally Advanced Nasopharyngeal Carcinoma First Affiliated Hospital of Guangxi Medical University 190
Testing effectiveness (Phase 2)Study completedNCT00524017What this trial is testingCetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive TractWho this might be right forHead and Neck CancerPrecancerous Condition Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Large-scale testing (Phase 3)Study completedNCT00004234What this trial is testingOral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or LarynxWho this might be right forHead and Neck CancerOral Complications NCIC Clinical Trials Group
Not applicableLooking for participantsNCT06356272What this trial is testingOropharynx (OPX) Biomarker TrialWho this might be right forClinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Oropharyngeal Squamous Cell Carcinoma+8 more Mayo Clinic 560
Large-scale testing (Phase 3)Ended earlyNCT01066741What this trial is testingPrevention of Radiation-induced Severe Oral Mucositis in Oral Cavity, Oropharynx, Hypopharynx, and Cavum CancerWho this might be right forOropharynx CancerHypopharynx Cancer Centre Leon Berard 78
Early research (Phase 1)Study completedNCT01445405What this trial is testingRadiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck CancerWho this might be right forCarcinoma, SquamousHead and Neck CancerOral Cancer+2 more National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)WithdrawnNCT05331131What this trial is testingEfficacy of Ketamine Mouthwash in the Management of Oral and Pharyngeal Toxicity Associated With Head and Neck Chemoradiotherapy: A Phase 2, Simon 2-stage TrialWho this might be right forCancer of Head and NeckMucositis OralPharyngeal Mucositis Northwell Health
Early research (Phase 1)Study completedNCT00003430What this trial is testingL-778,123 in Treating Patients With Recurrent or Refractory Solid TumorsWho this might be right forHead and Neck CancerUnspecified Adult Solid Tumor, Protocol Specific Memorial Sloan Kettering Cancer Center 40
Large-scale testing (Phase 3)Study completedNCT00117572What this trial is testingDocetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)Who this might be right forCancer of the PharynxCancer of the LarynxCancer of the Nasal Cavity+2 more University of Chicago 285
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013What this trial is testingNivolumab and Ipilimumab in Treating Patients With Rare TumorsWho this might be right forAcinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more National Cancer Institute (NCI) 798
Not applicableUnknownNCT00232960What this trial is testingPostoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCCWho this might be right forOral CancerOropharynx Cancer Gustave Roussy, Cancer Campus, Grand Paris 310
Large-scale testing (Phase 3)Study completedNCT00162708What this trial is testingVery Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCCWho this might be right forOropharynx CancerOral CancerHypopharynx Cancer+1 more Gustave Roussy, Cancer Campus, Grand Paris 120
Early research (Phase 1)Study completedNCT00978081What this trial is testingPhotodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck TumorsWho this might be right forHead and Neck CancerPrecancerous Condition Abramson Cancer Center at Penn Medicine 35
Testing effectiveness (Phase 2)Study completedNCT00004901What this trial is testingCombination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth CancerWho this might be right forHead and Neck Cancer Robert H. Lurie Cancer Center